• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌用于对抗医疗器械中的生物膜:一项系统评价与荟萃分析

The Use of Probiotics to Fight Biofilms in Medical Devices: A Systematic Review and Meta-Analysis.

作者信息

Carvalho Fábio M, Teixeira-Santos Rita, Mergulhão Filipe J M, Gomes Luciana C

机构信息

LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.

出版信息

Microorganisms. 2020 Dec 23;9(1):27. doi: 10.3390/microorganisms9010027.

DOI:10.3390/microorganisms9010027
PMID:33374844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7824608/
Abstract

Medical device-associated infections (MDAI) are a critical problem due to the increasing usage of medical devices in the aging population. The inhibition of biofilm formation through the use of probiotics has received attention from the medical field in the last years. However, this sparse knowledge has not been properly reviewed, so that successful strategies for biofilm management can be developed. This study aims to summarize the relevant literature about the effect of probiotics and their metabolites on biofilm formation in medical devices using a PRISMA-oriented (Preferred Reporting Items for Systematic reviews and Meta-Analyses) systematic search and meta-analysis. This approach revealed that the use of probiotics and their products is a promising strategy to hinder biofilm growth by a broad spectrum of pathogenic microorganisms. The meta-analysis showed a pooled effect estimate for the proportion of biofilm reduction of 70% for biosurfactants, 76% for cell-free supernatants (CFS), 77% for probiotic cells and 88% for exopolysaccharides (EPS). This review also highlights the need to properly analyze and report data, as well as the importance of standardizing the in vitro culture conditions to facilitate the comparison between studies. This is essential to increase the predictive value of the studies and translate their findings into clinical applications.

摘要

由于医疗设备在老年人群中的使用日益增加,与医疗设备相关的感染(MDAI)成为一个关键问题。近年来,通过使用益生菌来抑制生物膜形成受到了医学领域的关注。然而,这些稀少的知识尚未得到恰当的综述,因此无法制定出成功的生物膜管理策略。本研究旨在通过采用面向PRISMA(系统评价和Meta分析的首选报告项目)的系统检索和Meta分析,总结有关益生菌及其代谢产物对医疗设备中生物膜形成影响的相关文献。该方法表明,使用益生菌及其产品是一种有前景的策略,可阻碍多种致病微生物的生物膜生长。Meta分析显示,生物表面活性剂使生物膜减少比例的合并效应估计值为70%,无细胞上清液(CFS)为76%,益生菌细胞为77%,胞外多糖(EPS)为88%。本综述还强调了正确分析和报告数据的必要性,以及标准化体外培养条件以促进研究间比较的重要性。这对于提高研究的预测价值并将其结果转化为临床应用至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/e2f774369b7d/microorganisms-09-00027-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/bc739c796fec/microorganisms-09-00027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/21828f1b96ef/microorganisms-09-00027-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/1ca768d98f10/microorganisms-09-00027-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/4a83ada74dc2/microorganisms-09-00027-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/d8ab03cc52e5/microorganisms-09-00027-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/c8c947cead60/microorganisms-09-00027-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/e2f774369b7d/microorganisms-09-00027-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/bc739c796fec/microorganisms-09-00027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/21828f1b96ef/microorganisms-09-00027-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/1ca768d98f10/microorganisms-09-00027-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/4a83ada74dc2/microorganisms-09-00027-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/d8ab03cc52e5/microorganisms-09-00027-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/c8c947cead60/microorganisms-09-00027-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f685/7824608/e2f774369b7d/microorganisms-09-00027-g007.jpg

相似文献

1
The Use of Probiotics to Fight Biofilms in Medical Devices: A Systematic Review and Meta-Analysis.益生菌用于对抗医疗器械中的生物膜:一项系统评价与荟萃分析
Microorganisms. 2020 Dec 23;9(1):27. doi: 10.3390/microorganisms9010027.
2
Inhibition of Streptococcus mutans Growth and Biofilm Formation by Probiotics in vitro.体外益生菌对变形链球菌生长和生物膜形成的抑制作用。
Caries Res. 2017;51(2):87-95. doi: 10.1159/000452960. Epub 2017 Jan 25.
3
Use of Probiotics to Control Biofilm Formation in Food Industries.益生菌在食品工业中用于控制生物膜形成。
Antibiotics (Basel). 2023 Apr 14;12(4):754. doi: 10.3390/antibiotics12040754.
4
5
Effects of single- and multi-strain probiotics on biofilm formation and in vitro adhesion to bladder cells by urinary tract pathogens.单一和多菌株益生菌对尿路病原体生物膜形成和体外膀胱细胞黏附的影响。
Anaerobe. 2014 Jun;27:71-6. doi: 10.1016/j.anaerobe.2014.02.001. Epub 2014 Feb 25.
6
Extracellular polysaccharide derived from potential probiotic strain with antioxidant and antibacterial activities as a prebiotic agent to control pathogenic bacterial biofilm formation.源自具有抗氧化和抗菌活性的潜在益生菌菌株的细胞外多糖作为益生元剂来控制致病细菌生物膜的形成。
Microb Pathog. 2017 Aug;109:214-220. doi: 10.1016/j.micpath.2017.05.046. Epub 2017 Jun 2.
7
Inhibitory effect of probiotic lactobacilli supernatants on single and mixed non-albicans Candida species biofilm.益生菌乳杆菌上清液对单一和混合非白念珠菌生物膜的抑制作用。
Arch Oral Biol. 2018 Jan;85:40-45. doi: 10.1016/j.archoralbio.2017.10.002. Epub 2017 Oct 6.
8
Antimicrobial and antibiofilm activities of Clostridium butyricum supernatant against Acinetobacter baumannii.丁酸梭菌上清液对鲍曼不动杆菌的抗菌和抗生物膜活性。
Arch Microbiol. 2020 Jul;202(5):1059-1068. doi: 10.1007/s00203-020-01823-0. Epub 2020 Feb 4.
9
Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract.唾液链球菌 24SMB 和口腔链球菌 89a 等益生菌可干扰上呼吸道病原体的生物膜形成。
BMC Infect Dis. 2018 Dec 13;18(1):653. doi: 10.1186/s12879-018-3576-9.
10
Effects of a Novel Probiotic Combination on Pathogenic Bacterial-Fungal Polymicrobial Biofilms.新型益生菌组合对病原细菌-真菌多微生物生物膜的影响。
mBio. 2019 Apr 2;10(2):e00338-19. doi: 10.1128/mBio.00338-19.

引用本文的文献

1
Alterations of lung and gut microbiota in sodium butyrate alleviating heat stress-induced lung injury of broilers.丁酸钠对缓解热应激诱导的肉鸡肺损伤中肺和肠道微生物群的影响
Poult Sci. 2025 Feb;104(2):104796. doi: 10.1016/j.psj.2025.104796. Epub 2025 Jan 9.
2
The clinical praxis of bacteriocins as natural anti-microbial therapeutics.细菌素作为天然抗菌治疗剂的临床实践。
Arch Microbiol. 2024 Oct 30;206(11):451. doi: 10.1007/s00203-024-04152-8.
3
Advances in Microbial Exopolysaccharides: Present and Future Applications.微生物胞外多糖的研究进展:现状与未来应用。

本文引用的文献

1
Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations.细菌素作为新一代抗菌药物:毒性方面与法规。
FEMS Microbiol Rev. 2021 Jan 8;45(1). doi: 10.1093/femsre/fuaa039.
2
The Battle of Probiotics and Their Derivatives Against Biofilms.益生菌及其衍生物对抗生物膜之战
Infect Drug Resist. 2020 Feb 26;13:659-672. doi: 10.2147/IDR.S232982. eCollection 2020.
3
Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile?细菌素、强效抗菌肽与对抗多重耐药菌:耐药是否徒劳?
Biomolecules. 2024 Sep 16;14(9):1162. doi: 10.3390/biom14091162.
4
Molecular Mechanisms of Intestinal Protection by 23017 against C7731-Induced Damage: Role of Nrf2.23017对C7731诱导损伤的肠道保护分子机制:Nrf2的作用
Microorganisms. 2024 Jun 1;12(6):1135. doi: 10.3390/microorganisms12061135.
5
Exploring the In Vitro Antibacterial Potential of Specific Probiotic Strains against Oral Pathogens.探索特定益生菌菌株对口腔病原菌的体外抗菌潜力。
Microorganisms. 2024 Feb 21;12(3):441. doi: 10.3390/microorganisms12030441.
6
Protective Effect of Probiotics against Infection of Human Corneal Epithelial Cells.益生菌对人眼角膜上皮细胞感染的保护作用。
Int J Mol Sci. 2024 Feb 1;25(3):1770. doi: 10.3390/ijms25031770.
7
Genomic and phenotypic characterisation of Enterococcus mundtii AM_AQ_BC8 for its anti-biofilm, antimicrobial and probiotic potential.肠球菌 mundtii AM_AQ_BC8 的基因组和表型特征及其抗生物膜、抗菌和益生菌潜力。
Arch Microbiol. 2024 Jan 31;206(2):84. doi: 10.1007/s00203-023-03816-1.
8
Use of Probiotics to Control Biofilm Formation in Food Industries.益生菌在食品工业中用于控制生物膜形成。
Antibiotics (Basel). 2023 Apr 14;12(4):754. doi: 10.3390/antibiotics12040754.
9
Biofilms: Formation, drug resistance and alternatives to conventional approaches.生物膜:形成、耐药性及传统方法的替代方案
AIMS Microbiol. 2022 Jul 4;8(3):239-277. doi: 10.3934/microbiol.2022019. eCollection 2022.
10
Effect of Probiotics on Host-Microbiota in Bacterial Infections.益生菌对细菌感染中宿主-微生物群的影响。
Pathogens. 2022 Aug 29;11(9):986. doi: 10.3390/pathogens11090986.
Antibiotics (Basel). 2020 Jan 16;9(1):32. doi: 10.3390/antibiotics9010032.
4
Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.尿路致病性大肠埃希菌 FimH 在乳球菌中的表面展示:重组菌的体外特性及其在动物模型中的保护作用。
Microb Pathog. 2020 Apr;141:103974. doi: 10.1016/j.micpath.2020.103974. Epub 2020 Jan 8.
5
Probiotic Bifunctionality of -Rescuing Lactic Acid Bacteria from Desiccation and Antagonizing Pathogenic .益生菌的双重功能——从干燥环境中拯救乳酸菌并拮抗病原菌
Microorganisms. 2019 Sep 29;7(10):407. doi: 10.3390/microorganisms7100407.
6
Lactobacillus rhamnosus GG microcapsules inhibit Escherichia coli biofilm formation in coculture.鼠李糖乳杆菌 GG 微胶囊抑制共培养物中大肠杆菌生物膜的形成。
Biotechnol Lett. 2019 Sep;41(8-9):1007-1014. doi: 10.1007/s10529-019-02694-2. Epub 2019 May 30.
7
Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview.热灭活(廷德尔化)益生菌的健康益处:概述。
Int J Mol Sci. 2019 May 23;20(10):2534. doi: 10.3390/ijms20102534.
8
Evaluating Efficacy of Antimicrobial and Antifouling Materials for Urinary Tract Medical Devices: Challenges and Recommendations.评估用于尿路医疗器械的抗菌和抗污材料的疗效:挑战与建议。
Macromol Biosci. 2019 May;19(5):e1800384. doi: 10.1002/mabi.201800384. Epub 2019 Mar 18.
9
Inhibiting bacterial colonization on catheters: Antibacterial and antibiofilm activities of bacteriocins from Lactobacillus plantarum SJ33.抑制导管上的细菌定植:植物乳杆菌 SJ33 细菌素的抗菌和抗生物膜活性。
J Glob Antimicrob Resist. 2019 Dec;19:85-92. doi: 10.1016/j.jgar.2019.02.021. Epub 2019 Mar 7.
10
Lactobacillus plantarum Lipoteichoic Acid Inhibits Oral Multispecies Biofilm.植物乳杆菌脂磷壁酸抑制口腔多物种生物膜。
J Endod. 2019 Mar;45(3):310-315. doi: 10.1016/j.joen.2018.12.007.